A ironia usada por Krger em seu vdeo no toa
The STEP (Semaglutide Treatment Effect in People with obesity) trials, particularly STEP 1, demonstrated not only significant weight loss but also improvements in cardiometabolic risk factors, including lipid parameters
Eur J Prev Cardiol 29(17):22182237 Katta N, Loethen T, Lavie CJ, Alpert MA (2021) Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging
*Retatrutide is a novel medication that acts on GLP1, GIP, and Glucagon receptors
, , (, ) [32]
including semaglutide branded as Wegovy or Ozempic, and tirzepatide (dual GIP/GLP-1 receptor agonist) branded as Zepbound or Mounjaro, for the management of obesity, type 2 diabetes, and other metabolic conditions increases, so too does the need to assess the advantages and potential downsides of long-term use